964P Lenvatinib (L) and sorafenib (S) in patients (pts) with advanced or unresectable hepatocellular carcinoma (uHCC): An international, multicenter, phase IV study (STELLAR)

作者：M. Peck Radosavljevic, Ahmed Abdelgafur, Alessandro Granito, Antonio Gasbarrini, Y. Ma, Esther Mena, José Luis Lledó-Navarro, José Presa, A. Weinmann, Miriam Levy, A. Pellicelli, D. Waldschmidt, H.T. Sørensen, Lipika Goyal, Min Ren, Howard M. Saal, Chinyere E. Okpara, Tim Meyer · 发表于：Annals of Oncology · 年份：2024 · DOI：10.1016/j.annonc.2024.08.1024 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis